Literature DB >> 25143566

Phenotypic and genotypic changes over time and across facilities of serial colonizing and infecting Escherichia coli isolates recovered from injured service members.

Katrin Mende1, Miriam L Beckius2, Wendy C Zera3, Xin Yu2, Kristelle A Cheatle2, Deepak Aggarwal4, Ping Li4, Bradley A Lloyd5, David R Tribble4, Amy C Weintrob6, Clinton K Murray2.   

Abstract

Escherichia coli is the most common colonizing and infecting organism isolated from U.S. service members injured during deployment. Our objective was to evaluate the phenotypic and genotypic changes of infecting and colonizing E. coli organisms over time and across facilities to better understand their transmission patterns. E. coli isolates were collected via surveillance cultures and infection workups from U.S. military personnel injured during deployment (June 2009 to May 2011). The isolates underwent antimicrobial susceptibility testing, pulsed-field gel electrophoresis, and multiplex PCR for phylotyping to determine their resistance profiles and clonality. A total of 343 colonizing and 136 infecting E. coli isolates were analyzed, of which 197 (57%) and 109 (80%) isolates, respectively, produced extended-spectrum β-lactamases (ESBL). Phylogroup A was predominant among both colonizing (38%) and infecting isolates (43%). Although 188 unique pulsed-field types (PFTs) were identified from the colonizing isolates, and 54 PFTs were identified from the infecting isolates, there was a lack of PFT overlap between study years, combat zones, and military treatment facilities. On a per-subject basis, 26% and 32% of the patients with serial colonizing isolates and 10% and 21% with serial infecting isolates acquired changes in their phylogroup and PFT profiles, respectively, over time. The production of ESBL remained high over time and across facilities, with no substantial changes in antimicrobial susceptibilities. Overall, our results demonstrated an array of genotypic and phenotypic differences for the isolates without large clonal clusters; however, the same PFTs were occasionally observed in the colonizing and infecting isolates, suggesting that the source of infections may be endogenous host organisms.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25143566      PMCID: PMC4313217          DOI: 10.1128/JCM.00821-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  In harm's way: infections in deployed American military forces.

Authors:  Naomi E Aronson; John W Sanders; Kimberly A Moran
Journal:  Clin Infect Dis       Date:  2006-09-14       Impact factor: 9.079

2.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.

Authors:  Paul Scott; Gregory Deye; Arjun Srinivasan; Clinton Murray; Kimberly Moran; Ed Hulten; Joel Fishbain; David Craft; Scott Riddell; Luther Lindler; James Mancuso; Eric Milstrey; Christian T Bautista; Jean Patel; Alessa Ewell; Tacita Hamilton; Charla Gaddy; Martin Tenney; George Christopher; Kyle Petersen; Timothy Endy; Bruno Petruccelli
Journal:  Clin Infect Dis       Date:  2007-05-08       Impact factor: 9.079

3.  Further observations on the persistence of individual strains of Escherichia coli in the intestinal tract of man.

Authors:  H J SEARS; I BROWNLEE
Journal:  J Bacteriol       Date:  1952-01       Impact factor: 3.490

Review 4.  The injury severity score--importance and uses.

Authors:  S Linn
Journal:  Ann Epidemiol       Date:  1995-11       Impact factor: 3.797

5.  Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center.

Authors:  Kyle Petersen; Suzanne C Cannegieter; Tanny J van der Reijden; Beppie van Strijen; David M You; Britta S Babel; Andrew I Philip; Lenie Dijkshoorn
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

6.  Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center.

Authors:  Kristine M Hujer; Andrea M Hujer; Edward A Hulten; Saralee Bajaksouzian; Jennifer M Adams; Curtis J Donskey; David J Ecker; Christian Massire; Mark W Eshoo; Rangarajan Sampath; Jodi M Thomson; Philip N Rather; David W Craft; Joel T Fishbain; Allesa J Ewell; Michael R Jacobs; David L Paterson; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2006-09-25       Impact factor: 5.191

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  Real-time PCR for quantitative analysis of human commensal Escherichia coli populations reveals a high frequency of subdominant phylogroups.

Authors:  Mounira Smati; Olivier Clermont; Frédéric Le Gal; Olivier Schichmanoff; Françoise Jauréguy; Alain Eddi; Erick Denamur; Bertrand Picard
Journal:  Appl Environ Microbiol       Date:  2013-06-14       Impact factor: 4.792

9.  The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups.

Authors:  Olivier Clermont; Julia K Christenson; Erick Denamur; David M Gordon
Journal:  Environ Microbiol Rep       Date:  2012-12-24       Impact factor: 3.541

10.  Genetic diversity and temporal variation in the E. coli population of a human host.

Authors:  D A Caugant; B R Levin; R K Selander
Journal:  Genetics       Date:  1981-07       Impact factor: 4.562

View more
  8 in total

Review 1.  Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative.

Authors:  Katrin Mende; Kevin S Akers; Stuart D Tyner; Jason W Bennett; Mark P Simons; Dana M Blyth; Ping Li; Laveta Stewart; David R Tribble
Journal:  Mil Med       Date:  2022-05-04       Impact factor: 1.563

2.  Low Prevalence of carbapenem-resistant Enterobacteriaceae among wounded military personnel.

Authors:  Katrin Mende; Miriam L Beckius; Wendy C Zera; Fatma Onmus-Leone; Clinton K Murray; David R Tribble
Journal:  US Army Med Dep J       Date:  2017 Jul-Sep

3.  Lessons of war: Combat-related injury infections during the Vietnam War and Operation Iraqi and Enduring Freedom.

Authors:  Dana M Blyth; Heather C Yun; David R Tribble; Clinton K Murray
Journal:  J Trauma Acute Care Surg       Date:  2015-10       Impact factor: 3.313

4.  Early Infections Complicating the Care of Combat Casualties from Iraq and Afghanistan.

Authors:  Amy C Weintrob; Clinton K Murray; Jiahong Xu; Margot Krauss; William Bradley; Tyler E Warkentien; Bradley A Lloyd; David R Tribble
Journal:  Surg Infect (Larchmt)       Date:  2018-01-19       Impact factor: 2.150

5.  Resistance patterns and clinical significance of Candida colonization and infection in combat-related injured patients from iraq and afghanistan.

Authors:  Dana M Blyth; Katrin Mende; Amy C Weintrob; Miriam L Beckius; Wendy C Zera; William Bradley; Dan Lu; David R Tribble; Clinton K Murray
Journal:  Open Forum Infect Dis       Date:  2014-12-16       Impact factor: 3.835

6.  Emerging Infectious Diseases and Antimicrobial Resistance (EIDAR).

Authors:  Charlotte Lanteri; Katrin Mende; Mark Kortepeter
Journal:  Mil Med       Date:  2019-11-01       Impact factor: 1.437

7.  On the Etiological Relevance of Escherichia coli and Staphylococcus aureus in Superficial and Deep Infections - A Hypothesis-Forming, Retrospective Assessment.

Authors:  Hagen Frickmann; Andreas Hahn; Stefan Berlec; Johannes Ulrich; Moritz Jansson; Norbert Georg Schwarz; Philipp Warnke; Andreas Podbielski
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2019-10-16

8.  Clinical Characteristics and Resistance Patterns of Pseudomonas aeruginosa Isolated From Combat Casualties.

Authors:  Mary B Ford; Katrin Mende; Susan J Kaiser; Miriam L Beckius; Dan Lu; Jason Stam; Ping Li; Laveta Stewart; David R Tribble; Dana M Blyth
Journal:  Mil Med       Date:  2022-03-28       Impact factor: 1.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.